Variable | Category | No of patients | Median | 95% CI | Status of the patients | |||
---|---|---|---|---|---|---|---|---|
Censored | Even (Recovery) | |||||||
Count | Percent (%) | Count | Percent (%) | |||||
Sex | Female | 221 | 14 | [13, 15] | 35 | 39.3 | 186 | 41.7 |
Male | 314 | 12 | [11, 13] | 54 | 60.7 | 260 | 58.3 | |
Age group |  < 1 month | 3 | 8 | [7, 9] | 2 | 2.2 | 2 | 0.4 |
1–12 months | 243 | 12 | [12, 13] | 35 | 39.3 | 209 | 46.9 | |
13–36 months | 109 | 12 | [11, 13] | 19 | 21.3 | 90 | 20.2 | |
37–60 months | 48 | 12 | [11, 14] | 11 | 12.4 | 37 | 8.3 | |
 > 60 months | 132 | 12 | [13, 17] | 7 | 7.9 | 41 | 9.2 | |
Vaccination status | No | 158 | 13 | [12, 14] | 61 | 68.5 | 97 | 21.7 |
Yes | 377 | 12 | [11, 13] | 28 | 31.5 | 349 | 78.3 | |
Pathogens | Streptococcus pneumonia | 270 | 12 | [11, 14] | 22 | 24.7 | 166 | 37.2 |
Hemophilic influenza | 163 | 12 | [11, 14] | 58 | 65.2 | 202 | 45.3 | |
Neisseria meningitides | 80 | 13 | [12, 14] | 9 | 10.1 | 64 | 14.3 | |
Others | 22 | 15 | [12, 16] | 0 | 0.0 | 14 | 3.1 | |
Drug regime | Ceftriaxone and vancomycin | 120 | 14 | [12, 15] | 24 | 27.0 | 96 | 21.5 |
Ceftrazidime and vancomycin | 44 | 13 | [11, 18] | 10 | 11.2 | 34 | 7.6 | |
Ceftriaxone and dexamethine | 234 | 12 | [12, 14] | 36 | 40.4 | 198 | 44.4 | |
Cefoperatone and sulbactan | 24 | 13 | [11, 14] | 2 | 2.2 | 12 | 2.7 | |
Ciprofloxacin and ceftriaxone | 2 | 12 | [10, 13] | 1 | 1.1 | 1 | 0.2 | |
Ampiciline and gentamycin | 110 | 12 | [11, 13] | 14 | 15.7 | 96 | 21.5 | |
Others | 11 | 15 | [11, 17] | 2 | 2.2 | 9 | 2.0 | |
Residence place of the patients | Rural | 30 | 15 | [13, 18] | 7 | 7.9 | 23 | 5.2 |
Urban | 505 | 12 | [12, 13] | 82 | 92.1 | 423 | 94.8 | |
Comorbidies | Yes | 267 | 13 | [11, 13] | 19 | 21.3 | 248 | 55.6 |
No | 268 | 12 | [12, 14] | 70 | 78.7 | 198 | 44.4 | |
Breast feeding of the patients | Yes | 180 | 12 | [13, 15] | 52 | 58.4 | 142 | 31.8 |
No | 355 | 13 | [11, 13] | 37 | 41.6 | 304 | 68.2 |